Acadia Pharmaceuticals
ACAD
ACAD
210 hedge funds and large institutions have $3.61B invested in Acadia Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 64 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
210
Holders Change
-2
Holders Change %
-0.94%
% of All Funds
4.77%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.09%
New
36
Increased
82
Reduced
64
Closed
36
Calls
$24.9M
Puts
$35.6M
Net Calls
-$10.7M
Net Calls Change
+$16.6M
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$72.1M |
| 2 |
BBA
2
Baker Bros. Advisors
New York
|
$820M |
| 3 |
O
3
OrbiMed
New York
|
$25.6M |
| 4 |
4
Janus Henderson Group
London,
United Kingdom
|
$204M |
| 5 |
5
Morgan Stanley
New York
|
$27.1M |
